About us
We improve and save lives. We enable our customers to optimize the long-term value for patients through our innovative IVD solutions and services.

Who We Are
Ortho Clinical Diagnostics is a leading global provider of in vitro diagnostics.
We have an established track record for providing high-quality products and services
to the global clinical laboratory and immunohematology communities.

Our story
A Global Leader of In Vitro Diagnostics for over 80 years, Our purpose is simple: to improve and save lives with diagnostics. It’s what defines us. It’s made us a trusted partner of hospitals, hospital networks, blood banks, and labs around the world. And today it’s empowering us to advise our customers as they prepare for what’s next.

Clinicians count on lab professionals to deliver fast, accurate diagnostic insights that drive life-saving medical decisions. It’s why, at Ortho, we’re relentless in our commitment to deliver innovative, high-quality in vitro diagnostics to the hospitals, blood banks and independent labs we serve around the world.

Being considerate of the earth and its resources is a longstanding commitment of Ortho Clinical Diagnostics. Protecting the environment and advancing sustainability go hand-in-hand with our purpose of improving and saving lives.


Events not available


ICU Management

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack

2021 19 Jul

Ortho Clinical Diagnostics, one of the world’s largest pure-play in vitro diagnostics companies has announced its VITROS® Immunodiagnostic Products IL-6 Reagent Pack, the latest addition to Ortho’s VITROS® Critical Care menu, is now available in EU Countries, U.K. and several ASPAC and LATAM countries.* Results from Ortho’s IL-6 assay can be used... Read more

ICU Management

Statement From Ortho Clinical Diagnostics Regarding the Omicron Variant

2021 12 Jun

Ortho Clinical Diagnostics has been actively monitoring all 26 SARS-CoV-2 variants, including Omicron, on the potential impact to the performance of the VITROS® COVID-19 Testing Solutions including: VITROS® Anti-SARS-CoV-2 Total Assay* VITROS® Anti-SARS-CoV-2 IgG Assay* VITROS® Anti-SARS-CoV-2 IgG Quantitative Antibody Test* VITROS® SARS-CoV-2... Read more

ICU Management

Ortho’s VITROS® SARS-CoV-2 Antigen Test for High Volume COVID-19 Testing Receives CE Mark

2021 13 Apr

Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its VITROS® SARS-CoV-2 Antigen Test, initially launched in October 2020. The CE Mark allows for more convenient sample collection and expanded viral transport media. Updates to Ortho’s COVID-19... Read more

ICU Management

Ortho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available

2020 06 Dec

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received CE Mark for its VITROS ®  B•R•A•H•M•S PCT (Procalcitonin) assay, now commercially available to help clinicians identify sepsis and other severe bacterial infections. Ortho’s newest assay is available... Read more

Executive Health Management

ORTHO Optix™ Reader Now Available in CE Mark Countries, Completes Transfusion Medicine Portfolio

2020 30 Nov

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the CE Mark availability of the semi-automated ORTHO Optix™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected... Read more

Executive Health Management

Ortho’s Next Gen TSH3 Assay to Assess Thyroid and/or Pituitary Disorders Achieves CE Mark

2020 13 Nov

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics, today announced its VITROS® Immunodiagnostic Products TSH3 (Thyroid Stimulating Hormone) Reagent Pack and Calibrator has achieved CE Mark and will be commercially available in the beginning of December* to aid clinicians in assessing and diagnosing thyroid and/or pituitary gland... Read more

Executive Health Management

Ortho’s VITROS® COVID-19 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark

2020 26 Oct

Ortho’s new SARS-CoV-2 antigen test offers 98.9% concordance to real-time PCR tests, making it a viable alternative suitable for mass-scale testing Ortho’s new SARS-CoV-2 antigen test is the latest addition to the company’s COVID-19 solutions, which include two CE Marked and FDA EUA COVID-19 antibody tests – Total and IgG Ortho Clinical Diagnostics,... Read more

Executive Health Management

COVID-19 Total Antibody Test from Ortho Clinical Diagnostics Receives CE Mark

2020 12 May

- Ortho’s COVID-19 total antibody test receives CE Mark  -Ortho’s total antibody test may be used as aid in diagnosis and to support decisions for getting people back to work -The test offers excellent performance, with 100 percent specificity and sensitivity -Ortho began shipping its antibody test to customers in highly impacted geographies and plans... Read more

Jobs not available


    Catalogue not available

United States

White Papers - Case Studies

ICU Management

Maximizing the Benefits of COVID-19 Vaccines with the Right Serological Tests

2021 20 Oct

Background  Since the end of 2019, the world has been fighting the unprecedented global COVID-19 pandemic caused by SARSCoV-2. 1 This pandemic inspired significant efforts for the development of diagnostic tests, therapeutics and vaccines. 2,3,4 As a result, multiple efficacious COVID-19 vaccines have been developed and authorized in record speed5... Read more


    Videos not available


Not available


Not available

Revolutionize Your Lab Performance
Lab errors can delay diagnosis and treatment in some of a patient’s most crucial life moments. Let’s empower your lab to produce precise, rapid results so you can continue to provide top-quality care.

For more information, please visit: https://www.orthoclinicaldiagnostics.com/en-gb/home/improve-lab-performance

Achieve Cost Management
Labs of today need solutions that do more than just minimize lab spending. Ortho's automated systems bring highly accurate results and fewer training and maintenance hours. That means greater output and higher efficiency.

For more information, please visit: https://www.orthoclinicaldiagnostics.com/en-gb/home/achieve-cost-management

Enhance Clinical Outcomes
When even one inaccurate or delayed result can mean a life is on the line, you can count on Ortho Systems’ strong record of accuracy to deliver consistent results you can trust — and confidence in your treatment decisions.

For more information, please visit: https://www.orthoclinicaldiagnostics.com/en-gb/home/enhance-clinical-outcomes

Overcome Staffing Challenges
Staffing shortages can put pressure on the people you need the most. We can empower your lab with automated accuracy and efficiency that saves valuable hours ⁠— no matter the size of your team.

For more information, please visit:

Playing our part. How clinical laboratories can build a cleaner, more sustainable future

Find Ortho Clinical Diagnostics on Social Media

Ortho Clinical Diagnostics Webinar Replays

Changing Management for Changing Trends

A replay from 12 May 2021 - Click here

Embracing Sustainable Laboratory Medicine

A replay from 03 June 2021 - Click here

Joining the dots between patient and customer experience

A replay from 01 July 2021 - Click here

Key learnings from the COVID-19 Pandemic

A replay from 14 October 2021 - Click here

Creating value in Healthcare through laboratory medicine

A replay from 04 November 2021 - Click here

Interdisciplinary Acute Care: Past, Present and Future

A replay from 25 November 2021 - Click here